| Rosuvastatin (10mg/day)
N=21 |
| Variables |
Baseline
Mean (SD) |
After 2 years Treatment
Mean (SD) |
Changes |
Change (%) |
p |
| Total cholesterol(mg/dL) |
271 ± 70 |
148 ± 48 |
-123 |
45 |
0.001*** |
| LDL-cholesterol (mg/dL) |
202 ± 62 |
202 ± 62 |
- 97 |
48 |
0.001*** |
| Triglycerides (mg/dL) |
198 ± 90 |
126 ± 65 |
- 72 |
36 |
0.001*** |
| HDL-cholesterol(mg/dL |
39 ±13 |
49 ±14 |
+ 10 |
20 |
0.001*** |
| CIMT mean (mm) |
0.78 ± 0.09 |
0.67 ±0.11 |
- 0.11 |
14 |
0.001*** |
Decrease in lipoprotein levels from baseline CIMT after 2 years Rosuvastatin therapy. Ranges of total cholesterol reduced 45-55% and LDL-C reduced 48-65% |
